This webinar will examine 3D printing's potential impact on product liability laws as the technology becomes faster, cheaper, and more widespread. You will learn about possible alternative theories that plaintiffs may advance when someone is injured as a result of a designed or manufacturing defect in a 3D printed product. Particular attention will be given to the impact of 3D printing on FDA-regulated prescription medical products. Finally, you will hear an examination of various strategies that companies or potential product liability defendants - traditional and non-traditional - might use, prior to litigation, to minimize their possible exposure and mitigate the risk of liability.

Speakers: James M. Beck Senior Life Science Policy Analyst, Reed Smith LLP and Matthew D. Jacobson Associate, Reed Smith LLP.

To view this webinar on demand, please contact Webinar Requests.

For any questions, please contact the Events team at events@reedsmith.com.